{"nct_id":"NCT02008916","title":"16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients","status":"COMPLETED","status_verified_date":"2018-12","start_date":"2014-01-14","start_date_type":"ACTUAL","primary_completion_date":"2015-02-23","primary_completion_date_type":"ACTUAL","completion_date":"2017-12-11","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}